戻る Agenda
Day 1: Session 3:
Session Chair(s)
Anju Agarwal
Global PV Head
Advanz Pharma, United Kingdom
Speaker(s)
Day 1: Session 3.1: The challenges in front of ETHICS COMMITTEEs in India & way forward
Urmila Thatte
Seth GS Medical College & KEM Hospital, India
Emeritus Professor, Department of Clinical Pharmacology
Day 1: Session 3.2: An Analysis of Safety Profiles of Biologics vs Biosimilars
Nipom Deka
Amgen Inc., United States
Global Safety Medical Director, Immuno-Oncology Therapeutic Area
Day 1: Session 3.3: US FDA Approaches towards Vaccine Vigilance – MAH Perspective
Sanjeev Miglani, MD
AWINSA Life Sciences, United States
Founder and Director